PQ 47
47. Deputy Clare Daly asked the Taoiseach and Minister for Defence further to Question No. 262 of 30 March 2017 and the clarification of 13 June 2017 (details supplied), the year in which the Defence Forces were first of the view that the specific reactions of anxiety, restlessness or confusion, if declared by a member of the Defence Forces to be present, would necessitate withdrawal of mefloquine. [32348/17]
Introduced
11 July 2017
Last action
—
Status
oral
Sponsors
—
Subjects
Discovery layer
Source updated
11 July 2017
Summary
47. Deputy Clare Daly asked the Taoiseach and Minister for Defence further to Question No. 262 of 30 March 2017 and the clarification of 13 June 2017 (details supplied), the year in which the Defence Forces were first of the view that the specific reactions of anxiety, restlessness or confusion, if declared by a member of the Defence Forces to be present, would necessitate withdrawal of mefloquine. [32348/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Defence Forces Medicinal Products
Defence Forces Medicinal Products
xml · EN · 11 July 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-07-11/47/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-07-11/pq_47